Predictive Oncology Investor Relations Material

Predictive Oncology Inc. focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States using state-of-the-art molecular profiling and diagnostics that drive precision medicine forward, creating next generation cancer treatments with improved patient outcomes. The company applies its unique technology in an evidence based manner to ensure the quality and validity of its products.